The Cosmetic, Toiletry, & Fragrance Association (CTFA) has filed comprehensive comments with the FDA on the science and regulation of nanoparticles in personal care products.
FDA’s Recent Exemptions: What Do They Mean as We Finalize DSCSA Implementation?
October 31st 2024Kala Shankle, Vice President of Regulatory Affairs with the Healthcare Distribution Alliance, and Ilisa Bernstein, President of Bernstein Rx Solutions, LLC, discussed recent developments regarding the Drug Supply Chain Security Act.